Martin Bohlin

New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound

A novel compound form

Crystalline form of the S-enantiomer of omeprazole

A process for preparing [1s- [1-alpha, 2-alpha, 3-beta (1s*, 2r*) 5-beta] ] -3- [7- [2- (3, 4-dif luorophenyl) -cyclopropylamino] - 5- (propylthio) -3h-1, 2, 3-triazolo [4, 5-d] pyrimidin-3-yl] -5- (2- hydroxyethoxy) cyclopentane-1, 2-diol and to its intermediates

Novel crystalline forms of the anti-cancer compound zd1839

Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compound

A process for the preparation of (3ar,4s, 6r, 6as)-6-amino-2, 2- dimethyltetrahydro-3ah-cyclopenta[d] [1,3] dioxol-4-ol dibenzoyl-l-tartrate and to products of said process

New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt

Crystalline naloxol-peg conjugate

Crystalline forms of n- {2-tert -butyl -1- [ (4,4- dif luorocyclohexyl) methyl] -lh-benzimidazol-5- yl}ethanesulfonamide salts